Methylcobalamin proven effective for diabetic neuropathy, but regulatory delay stalls official ban lift
Despite scientific evidence supporting the efficacy of methylcobalamin, particularly in the treatment of diabetic neuropathy, the Union ministry of health’s lifting of the ban on this essential nutrient has yet to be formalized through a gazette notification. Methylcobalamin, a form of vitamin B12, plays a critical role in the management of various conditions, including diabetic neuropathy, but its availability remains complicated due to the lack of regulatory clarity.
